|
rdfs:label
|
"Ivacaftor"@es
"Ivacaftor"@pt
"Ivakaftor"@sh
"Ivakaftor"@sr
"ivacaftor"@en
"ivacaftor"@fr
"ivacaftor"@nl
"ivacaftorum"@la
"ivakaftor"@sl
"iwakaftor"@pl
"איבקפטור"@he
"إيفاكافتور"@ar
"ایواکافتور"@azb
"ایواکافتور"@fa
"ଇଭାକାଫ୍ଟର"@or
"イヴァカフトール"@ja
"依伐卡托"@zh
|
|
skos:altLabel
|
"Ivacaftor"@sr
"Kalideko"@sr
"Kalydeco"@sr
"N-(2,4-di-tert-butil-5-hidroksifenil)-4-okso-1,4-dihidrohinolin-3-karboksamid"@sr
"N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide"@en
"VX-770"@en
"VX-770"@pl
"VX-770"@sr
"イバカフトル"@ja
|
|
schema:description
|
"chemická sloučenina"@cs
"chemische Verbindung"@de
"chemische verbinding"@nl
"component quimic"@oc
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemična spojina; učinkovina"@sl
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"konposatu kimiko"@eu
"lek stosowany w leczeniu mukowiscydozy, wzmacniający działanie białka CFTR"@pl
"pharmaceutical drug"@en
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ଏହାଏକ ଔଷଧ ଯାହା ସିଷ୍ଟିକ୍ ଫାଇବ୍ରୋସିସ୍ ରୋଗର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।"@or
|
|
schema:dateModified
|
"2026-06-29T05:16:14+00:00"^^xsd:dateTime
|
|
schema:version
|
2511702298
|
|
wikibase:identifiers
|
32
|
|
wikibase:sitelinks
|
15
|
|
wikibase:statements
|
47
|
|
p:P10245
|
wd:statement/Q6095693-74beae5f-443b-1c05-fc56-e15c1b5bb6ae
|
|
p:P10283
|
wd:statement/Q6095693-EF5324D0-8CF2-41D6-8DAF-09D623812859
|
|
p:P11089
|
wd:statement/Q6095693-E3905093-1E4A-424F-A498-9ABA4842CD09
|
|
p:P11143
|
wd:statement/Q6095693-517BE9FE-EE2E-446B-9409-5A0AF9983BAE
|
|
p:P11198
|
wd:statement/Q6095693-69F88B47-87DB-4B57-95A3-7A9FFBDC2E24
|
|
p:P11199
|
wd:statement/Q6095693-EB124635-BD9F-4E74-9E1D-13F8FC2CD5EB
|
|
p:P117
|
wd:statement/Q6095693-57256f32-4315-7bb7-88df-59e6649680a8
|
|
p:P129
|
wd:statement/Q6095693-6F8E80AD-A207-44B0-BF83-8BB57BE285F2
|
|
p:P2057
|
wd:statement/Q6095693-232A8BCA-2DE3-4D83-93B5-5A5144BCD47B
|
|
p:P2067
|
wd:statement/Q6095693-7E41C2F9-3CD4-4936-B018-3999BD739783
|
|
p:P2115
|
wd:statement/Q6095693-CA7709EA-53ED-43B9-BA6C-94DFB065DA7C
|
|
p:P2175
|
wd:statement/Q6095693-4583720E-BD87-4E56-9C7C-E00F167B68B1
|
|
p:P231
|
wd:statement/Q6095693-85A9E561-8FA5-4584-923E-2ACDDBC0E153
|
|
p:P232
|
wd:statement/Q6095693-127388F4-7F2D-404B-AAB8-FFFEE5549B39
|
|
p:P233
|
wd:statement/Q6095693-E1AF7437-2CA0-4B9B-9145-CE215C262CF2
|
|
p:P234
|
wd:statement/Q6095693-78B45F88-C942-4839-99C6-26FE7D340EC9
|
|
p:P235
|
wd:statement/Q6095693-ABD4E7E0-C1BB-45C6-A20B-C1DB11CC45CD
|
|
p:P2566
|
wd:statement/Q6095693-98032A73-D70A-497A-AF94-72E769AAA9F4
|
|
p:P267
|
wd:statement/Q6095693-7AE3FD06-0734-4D9F-94EF-E1165C3DA4A9
|
|
p:P274
|
wd:statement/Q6095693-B9A57052-616F-4E8C-AC28-807BEBC66DC1
|
|
p:P279
|
wd:statement/Q6095693-D44483DF-E86C-4E1F-B3C8-90BD21BC3759
|
|
p:P2868
|
wd:statement/Q6095693-0B09A87F-D55C-4520-AACD-5E91E5679F67
|
|
wd:statement/Q6095693-72AD74A0-E4DC-4643-AC34-82CA19533AB5
|
|
p:P2877
|
wd:statement/Q6095693-49D3746E-FBD7-4D1B-9F24-C96781ADBBC5
|
|
p:P2892
|
wd:statement/Q6095693-5E5A8730-3021-4A4C-B3AF-2B926DE774FA
|
|
p:P31
|
wd:statement/Q6095693-DF6D59BA-B9E6-4445-98FA-D1DBE429AAA0
|
|
p:P3117
|
wd:statement/Q6095693-1EC3F83D-1595-460E-A81B-15FA2553427C
|
|
p:P3345
|
wd:statement/Q6095693-79B24EFB-37A8-4B1B-8031-8D5A398AF789
|
|
p:P3489
|
wd:statement/Q6095693-DDAFAAC9-AA60-4316-BEF1-B69E209725DD
|
|
p:P3636
|
wd:statement/Q6095693-30CD9617-A331-464D-9307-92FDDEC8DFE8
|
|
p:P366
|
wd:statement/Q6095693-8A815A41-0C6B-48F9-B53B-4FB127EEA949
|
|
p:P373
|
wd:statement/Q6095693-6e7e7cf4-e863-4f6d-af31-7a3f769fcd8d
|
|
p:P3780
|
wd:statement/Q6095693-813034B2-AA07-4579-9168-B5E8ABD949C7
|
|
p:P4250
|
wd:statement/Q6095693-99226AD1-C3D9-45D9-8EC7-F0081A2F1282
|
|
p:P486
|
wd:statement/Q6095693-6E13B04C-4A47-467F-80C6-C3261B30EFA7
|
|
p:P4964
|
wd:statement/Q6095693-7B67EAAE-DF2A-4ACF-8A91-06EA5B58190B
|
|
p:P592
|
wd:statement/Q6095693-4C1540AA-0FC8-40F3-BE92-B8DD614476C0
|
|
p:P595
|
wd:statement/Q6095693-3A122B55-BECA-4CFD-8BF7-049CC5018F12
|
|
p:P6366
|
wd:statement/Q6095693-3EA83EA4-367D-4DB5-B15A-57CB41463068
|
|
p:P646
|
wd:statement/Q6095693-7C135745-9419-4404-BFCF-C0C7A4DF4766
|
|
p:P652
|
wd:statement/Q6095693-B144FC10-A7E9-4A99-8D9E-BED0EDFE362A
|
|
p:P661
|
wd:statement/Q6095693-571F71FC-FBBF-4AFE-97BD-5426B05F6D2B
|
|
p:P662
|
wd:statement/Q6095693-9962C7B8-8F45-43BF-927F-9028B56CB5CD
|
|
p:P665
|
wd:statement/Q6095693-B3531BAC-4191-4392-B4C6-FC1B3B990F71
|
|
p:P683
|
wd:statement/Q6095693-BDAADB44-5EDA-4177-96F2-BA0071606480
|
|
p:P715
|
wd:statement/Q6095693-86C6A67A-2D8C-45C5-9721-189304E44D71
|
|
p:P8494
|
wd:statement/Q6095693-86D80F42-50BC-4AF3-A9FB-2E9E399E54EB
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000185033>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/C545203>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL2010601>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2776502428>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/17347474>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16220172>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D09916>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_66901>
|
|
wdt:P10245
|
"a612012"
|
|
wdt:P10283
|
"C2776502428"
|
|
wdt:P11089
|
"1076838"
|
|
wdt:P11143
|
"Ivacaftor"
|
|
wdt:P11198
|
"4228"
|
|
wdt:P11199
|
"PD009194"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Ivacaftor.svg>
|
|
wdt:P129
|
cystic fibrosis transmembrane conductance regulator
|
|
wdt:P2057
|
"HMDB0015705"
|
|
wdt:P2067
|
392.209993^^xsd:decimal
|
|
wdt:P2115
|
"N0000185033"
|
|
wdt:P2175
|
cystic fibrosis
|
|
wdt:P231
|
"873054-44-5"
|
|
wdt:P232
|
"800-027-5"
|
|
wdt:P233
|
"CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C"
|
|
wdt:P234
|
"InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)"
|
|
wdt:P235
|
"PURKAOJPTOLRMP-UHFFFAOYSA-N"
|
|
wdt:P2566
|
"100.226.211"
|
|
wdt:P267
|
"R07AX02"
|
|
wdt:P274
|
"C₂₄H₂₈N₂O₃"
|
|
wdt:P279
|
chemical compound
|
|
wdt:P2868
|
xenobiotic-transporting ATPase inhibitor
|
|
chloride channel agonist
|
|
wdt:P2877
|
"351373"
|
|
wdt:P2892
|
"C3264621"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID00236281"
|
|
wdt:P3345
|
"1243041"
|
|
wdt:P3489
|
US pregnancy category B
|
|
wdt:P3636
|
"VX7"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Ivacaftor"
|
|
wdt:P3780
|
Kalydeco
|
|
wdt:P4250
|
0.3^^xsd:decimal
|
|
wdt:P486
|
"C545203"
|
|
wdt:P4964
|
"splash10-0079-1809000000-c0147e018d786aee606b"
|
|
wdt:P592
|
"CHEMBL2010601"
|
|
wdt:P595
|
"4342"
|
|
wdt:P6366
|
"2776502428"
|
|
wdt:P646
|
"/m/0gg58cr"
|
|
wdt:P652
|
"1Y740ILL1Z"
|
|
wdt:P661
|
"17347474"
|
|
wdt:P662
|
"16220172"
|
|
wdt:P665
|
"D09916"
|
|
wdt:P683
|
"66901"
|
|
wdt:P715
|
"DB08820"
|
|
wdt:P8494
|
"DTXCID00158772"
|